Literature DB >> 28741333

HIV-affected couples and individuals who desire children should be offered options for safer conception.

Lealah C Pollock1, Shannon Weber1, Angela Kaida2, Lynn T Matthews3, Dominika L Seidman4.   

Abstract

Entities:  

Keywords:  HIV; human immunodeficiency virus; natural conception; patient-centred counselling; safer conception; serodiscordant

Mesh:

Year:  2017        PMID: 28741333      PMCID: PMC5577738          DOI: 10.7448/IAS.20.1.22155

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


× No keyword cloud information.
Safier and Sauer argue that assisted reproductive technologies should be recommended as the first-line conception strategy for HIV-affected couples desiring children [1]. We agree with honouring the reproductive goals and preferences of individuals and couples affected by HIV. However, given the evidence that HIV-affected couples can achieve pregnancy through condomless sex with zero or near-zero risk of HIV transmission [2], we disagree with the authors’ assertion that assisted reproductive technologies should be the treatment of choice over other safer conception strategies. Women and men living with HIV desire counselling on a range of safer conception options; offering this counselling will allow individuals to meet their reproductive goals while minimizing HIV transmission [3,4]. Research demonstrates that “condomless sex” does not necessarily indicate “unprotected sex”: sustained use of antiretroviral therapy (ART) to achieve a suppressed viral load in partners living with HIV, known as treatment as prevention (TasP), is associated with zero or near-zero risk of sexual HIV transmission [5,6]. Indeed, there are no reported cases of penile–vaginal transmission in the setting of an undetectable viral load [7]. Both prospective cohort and modelling studies suggest that antiretroviral therapy for partners living with HIV combined with genital tract infection screening and condomless sex limited to peak fertility maximizes the likelihood of pregnancy while minimizing, or eliminating, sexual HIV transmission [8,9]. For individuals or couples who desire additional protection, or when partners living with HIV take ART inconsistently, pre-exposure prophylaxis (PrEP) offers a safe and highly effective method to reduce HIV acquisition risk while allowing for conception [10]. As noted in the editorial accompanying the recent supplement, “healthcare providers should support informed, voluntary decision-making about reproductive choices, to create environments that reduce stigma associated with HIV” [11]. With multiple safe and effective conception options available, providers have an obligation to inquire about each person’s values and preferences and provide counselling that supports informed decision-making. Promoting only one option imposes counsellors’ preferences over couples’ preferences, which might include prioritizing relationship intimacy or minimizing interventions. Eliciting and respecting these preferences engages patients in shared decision-making [12]. Finally, Safier and Sauer argue that there are two strata of HIV-affected couples: those who can afford and access the “preferred treatment option” and those who cannot. Reproductive health counselling must be grounded in a reproductive justice framework: options for safer conception should be available to all HIV-affected individuals and couples. Assisted reproductive technologies are essential when spontaneous conception is not possible, such as for same sex couples, single parents by choice and couples affected by infertility. In addition, some HIV-affected couples may prefer to use assisted reproductive technologies for all of the reasons outlined by Safier and Sauer. Infertility specialists have played a critical role in supporting the reproductive rights of persons living with HIV [13]. They will continue to do so by making safe and effective services available to clients who need and want them. All providers caring for people affected by HIV can support their patients by counselling about reproductive options in a client-centred, evidence-based, and rights-based manner.
  12 in total

1.  Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners.

Authors:  Risa M Hoffman; Amber Jaycocks; Raffaele Vardavas; Glenn Wagner; Jordan E Lake; Deborah Mindry; Judith S Currier; Raphael J Landovitz
Journal:  J Infect Dis       Date:  2015-06-19       Impact factor: 5.226

Review 2.  PrEP as Peri-conception HIV Prevention for Women and Men.

Authors:  Renee Heffron; Jillian Pintye; Lynn T Matthews; Shannon Weber; Nelly Mugo
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

3.  Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network.

Authors:  Louis Bujan; Lital Hollander; Mathieu Coudert; Carole Gilling-Smith; Alexandra Vucetich; Juliette Guibert; Pietro Vernazza; Jeanine Ohl; Michael Weigel; Yvon Englert; Augusto E Semprini
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

4.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

5.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

6.  Consensus statement: Supporting Safer Conception and Pregnancy For Men And Women Living with and Affected by HIV.

Authors:  Lynn T Matthews; Jolly Beyeza-Kashesya; Ian Cooke; Natasha Davies; Renee Heffron; Angela Kaida; John Kinuthia; Okeoma Mmeje; Augusto E Semprini; Shannon Weber
Journal:  AIDS Behav       Date:  2018-06

7.  Ask women living with HIV what's needed to achieve safe pregnancies in serodifferent relationships.

Authors:  Luisa Orza; Susan Bewley; E Tyler Crone; Lillian Mworeko; Angelina Namiba; Teresia Otieno; Marijo Vazquez; Alice Welbourn
Journal:  J Int AIDS Soc       Date:  2017-03-08       Impact factor: 5.396

8.  Supporting people living with HIV in serodiscordant partnerships to attempt a desired pregnancy by integrating sexual and reproductive health and HIV interventions.

Authors:  Manjulaa Narasimhan; Connie Celum; Ian Askew; James Kiarie; Sheryl van der Poel
Journal:  J Int AIDS Soc       Date:  2017-03-08       Impact factor: 5.396

9.  Natural conception in HIV-serodiscordant couples with the infected partner in suppressive antiretroviral therapy: A prospective cohort study.

Authors:  Jorge Del Romero; María Begoña Baza; Isabel Río; Adrián Jerónimo; Mar Vera; Victoria Hernando; Carmen Rodríguez; Jesús Castilla
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Fertility care interventions should be provided as the first line options for HIV+ serodiscordant couples who desire children in settings with affordable access to care, regardless of their fertility status.

Authors:  Lauren Zakarin Safier; Mark V Sauer
Journal:  J Int AIDS Soc       Date:  2017-03-08       Impact factor: 5.396

View more
  2 in total

1.  High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception Services.

Authors:  Angela Kaida; Jerome Kabakyenga; Mwebesa Bwana; Francis Bajunirwe; Winnie Muyindike; Kara Bennett; Annet Kembabazi; Jessica E Haberer; Yap Boum; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Lynn T Matthews
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

2.  Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.

Authors:  Catherine S Todd; Heidi E Jones; Nontokozo Langwenya; Donald R Hoover; Pai-Lien Chen; Gregory Petro; Landon Myer
Journal:  PLoS Med       Date:  2020-05-22       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.